Healthcare | May 22, 2026
APHI welcomes CCI order on integrated healthcare delivery model
The ruling brings closure to a nearly decade-long investigation into hospital operations and healthcare delivery practices
The ruling brings closure to a nearly decade-long investigation into hospital operations and healthcare delivery practices
Pfizer says the broader dataset across all 25 serotypes strengthens confidence that the program can meet non-inferiority thresholds in its upcoming Phase 3 pediatric trials
NEJM study shows strong protection across strains
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The company says the platform offers improved manufacturability and functional advantages
TG4050 harnesses Transgene’s myvac platform and NEC’s AI-powered neoantigen prediction technology to tailor vaccines to each patient’s tumor
A key milestone in this journey has been the introduction of TREAT Program, a first-of-its-kind clinical initiative introduced in India
The trial demonstrated that immune responses in children were non-inferior to adults, with a similar safety profile after two standard doses of MVA-BN
The company plans to submit the vaccine for regulatory review
Previously, Arexvy was authorized for adults 60 and older, and for those 50–59 with heightened risk
Subscribe To Our Newsletter & Stay Updated
